These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 423181)

  • 1. 5-Iminodaunorubicin. Reduced cardiotoxic properties in an antitumor anthracycline.
    Tong GL; Henry DW; Acton EM
    J Med Chem; 1979 Jan; 22(1):36-9. PubMed ID: 423181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antitumor anthracycline antibiotics. Structure-activity and structure-cardiotoxicity relationships of rubidazone analogues.
    Tong GL; Cory M; Lee WW; Henry DW
    J Med Chem; 1978 Aug; 21(8):732-7. PubMed ID: 690999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of daunorubicin analogues with novel 9-acyl substituents.
    Smith TH; Fujiwara AN; Henry DW
    J Med Chem; 1979 Jan; 22(1):40-4. PubMed ID: 423182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diminished superoxide anion generation by reduced 5-iminodaunorubicin relative to daunorubicin and the relationship to cardiotoxicity of the anthracycline antitumor agents.
    Lown JW; Chen HH; Plambeck JA; Acton EM
    Biochem Pharmacol; 1979 Sep; 28(17):2563-8. PubMed ID: 229856
    [No Abstract]   [Full Text] [Related]  

  • 5. Synthesis of 4-demethoxy-11-deoxy-analogs of daunomycin and adriamycin.
    Umezawa H; Takahashi Y; Konoshita M; Naganawa H; Tatsuta K; Takeuchi T
    J Antibiot (Tokyo); 1980 Dec; 33(12):1581-5. PubMed ID: 7195898
    [No Abstract]   [Full Text] [Related]  

  • 6. Synthesis and antileukemic activity of N-enamine derivatives of daunorubicin, 5-iminodaunorubicin, and doxorubicin.
    Stefańska B; Dzieduszycka M; Bontemps-Gracz M; Borowski E; Martelli S
    J Antibiot (Tokyo); 1988 Feb; 41(2):193-8. PubMed ID: 3356607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular pharmacology of N,N-dimethyl daunorubicin and N,N-dimethyl adriamycin.
    Egorin MJ; Clawson RE; Ross LA; Bachur NR
    Cancer Res; 1980 Jun; 40(6):1928-33. PubMed ID: 7371027
    [No Abstract]   [Full Text] [Related]  

  • 8. 3'-deamino-3'-morpholino derivatives of daunomycin, adriamycin and carminomycin.
    Takahashi Y; Kinoshita M; Masuda T; Tatsuta K; Takeuchi T; Umezawa H
    J Antibiot (Tokyo); 1982 Jan; 35(1):117-8. PubMed ID: 7068512
    [No Abstract]   [Full Text] [Related]  

  • 9. Molecular pharmacological differences between carminomycin and its analog, carminomycin-11-methyl ether, and adriamycin.
    DuVernay VH; Pachter JA; Crooke ST
    Cancer Res; 1980 Feb; 40(2):387-94. PubMed ID: 7356521
    [No Abstract]   [Full Text] [Related]  

  • 10. Cellular pharmocodynamics of several anthrocycline antibiotics.
    Bachur NR; Steele M; Meriwether WD; Hildebrand RC
    J Med Chem; 1976 May; 19(5):651-4. PubMed ID: 1271407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Total synthesis of the antitumor antibiotic danuorubicin. Coupling of the sugar and aglycone.
    Acton EM; Fujiwara AN; Henry DW
    J Med Chem; 1974 Jun; 17(6):659-60. PubMed ID: 4829947
    [No Abstract]   [Full Text] [Related]  

  • 12. Cytotoxicity and DNA strand breaks by 5-iminodaunorubicin in mouse leukemia L1210 cells: comparison with adriamycin and 4'-(9-acridinylamino)methanesulfon-m-anisidide.
    Zwelling LA; Kerrigan D; Michaels S
    Cancer Res; 1982 Jul; 42(7):2687-91. PubMed ID: 6896293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biological activities of rubidazone.
    Maral R
    Cancer Chemother Pharmacol; 1979; 2(1):31-5. PubMed ID: 498417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Baumycins, new antitumor antibiotics related to daunomycin.
    Komiyana T; Matsuzawa Y; Oki T; Inui T; Takahashi Y; Naganawa H; Takeuchi T; Umezawa H
    J Antibiot (Tokyo); 1977 Jul; 30(7):619-21. PubMed ID: 561047
    [No Abstract]   [Full Text] [Related]  

  • 15. [Synthesis and antitumor properties of 3'-desamino-3'-dimethylformamidinorubomycin].
    Povarov LS; Ul'ianova LA; Tarasova VE; Odnoralets EN; Iudina OI
    Antibiot Khimioter; 1988 Jun; 33(6):448-52. PubMed ID: 3421770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative biochemical studies of adriamycin and daunomycin in leukemic cells.
    Wang JJ; Chervinsky DS; Rosen JM
    Cancer Res; 1972 Mar; 32(3):511-5. PubMed ID: 5061305
    [No Abstract]   [Full Text] [Related]  

  • 17. Adriamycin analogues. 3. Synthesis of N-alkylated anthracyclines with enhanced efficacy and reduced cardiotoxicity.
    Tong GL; Wu HY; Smith TH; Henry DW
    J Med Chem; 1979 Aug; 22(8):912-8. PubMed ID: 490536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Synthesis of rubomycin 13-tert-butoxycarbonylhydrazone and the study of its antitumor action].
    Povarov LS; Gol'dberg LE; Bazhanov VS; Olsuf'eva EN; Averbukh LA
    Antibiotiki; 1981 Nov; 26(11):813-6. PubMed ID: 6895688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and antitumor activity of 4-demethoxydaunorubicin, 4-demethoxy-7,9-diepidaunorubicin, and their beta anomers.
    Arcamone F; Bernardi L; Giardino P; Patelli B; Marco A; Casazza AM; Pratesi G; Reggiani P
    Cancer Treat Rep; 1976 Jul; 60(7):829-34. PubMed ID: 1009518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experimental and clinical activity of a new anthracycline derivative: detorubicin (14-diethoxyacetoxydaunorubicin).
    Maral R; Heusse D; Lavelle F; Cueille G; Marlard M; Jacquillat C; Maral J; Auclerc MF; Weil M; Auclerc G; Bernard J
    Recent Results Cancer Res; 1980; 74():172-83. PubMed ID: 7444138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.